Summary
This 8-K filing from Quest Diagnostics Inc. (DGX) on January 7, 2013, primarily announces changes regarding executive officers and their participation in the company's severance plan. Specifically, Everett Cunningham and John B. Haydon were appointed as executive officers on January 1, 2013. This designation also makes them Schedule B Participants in the company's Executive Officer Severance Plan.
Key Highlights
- 1Everett Cunningham, Senior Vice President, Commercial, appointed as an executive officer.
- 2John B. Haydon, Senior Vice President, Operations, appointed as an executive officer.
- 3Appointment effective January 1, 2013.
- 4Both executives are now Schedule B Participants in the Executive Officer Severance Plan.
- 5The company has filed an Amended and Restated Executive Officer Severance Plan as an exhibit.
Frequently Asked Questions
Becoming executive officers signifies a promotion and increased responsibility within Quest Diagnostics. It also triggers their eligibility for the company's Executive Officer Severance Plan.
The Executive Officer Severance Plan is a company-sponsored program designed to provide certain benefits to executive officers in the event of their termination under specific circumstances, as detailed in the plan documents.
The filing indicates the plan was amended and restated to include updated Schedules A and B, likely to reflect the addition of new participants like Mr. Cunningham and Mr. Haydon, or to revise existing terms and conditions.
No, this specific filing does not report any departures. It only announces the appointment of new executive officers and their inclusion in the severance plan.